The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport

UniProt: a hub for protein information

(2014)   NUCLEIC ACIDS RESEARCH

Structure–Activity Relationships of Chromone Derivatives toward the Mechanism of Interaction with and Inhibition of Breast Cancer Resistance Protein ABCG2

(2013) Evelyn Winter et al.   JOURNAL OF MEDICINAL CHEMISTRY

CNA web server: rigidity theory-based thermal unfolding simulations of proteins for linking structure, (thermo-)stability, and function

(2013) Dennis M. Krüger et al.   NUCLEIC ACIDS RESEARCH

Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans

(2012) Mi Sun Jin et al.   NATURE

Substituted Chromones as Highly Potent Nontoxic Inhibitors, Specific for the Breast Cancer Resistance Protein

(2011) Glaucio Valdameri et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and Characterization of a BODIPY Conjugate of the BCR-ABL Kinase Inhibitor Tasigna (Nilotinib): Evidence for Transport of Tasigna and Its Fluorescent Derivative by ABC Drug Transporters

(2011) Suneet Shukla et al.   MOLECULAR PHARMACEUTICS

Nilotinib (AMN107, Tasigna ® ) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters

(2009) Amit K. Tiwari et al.   BIOCHEMICAL PHARMACOLOGY

Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

(2009) S. G. Aller et al.   SCIENCE

Homology modeling of breast cancer resistance protein (ABCG2)

(2008) Eszter Hazai et al.   JOURNAL OF STRUCTURAL BIOLOGY

The Jpred 3 secondary structure prediction server

(2008) C. Cole et al.   NUCLEIC ACIDS RESEARCH